Nationwide Fund Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | – | Sell |
-7,245
| Closed | -$38K | – | 3283 |
|
2017
Q1 | $38K | Hold |
7,245
| – | – | ﹤0.01% | 3027 |
|
2016
Q4 | $34K | Hold |
7,245
| – | – | ﹤0.01% | 3050 |
|
2016
Q3 | $48K | Hold |
7,245
| – | – | ﹤0.01% | 3052 |
|
2016
Q2 | $40K | Hold |
7,245
| – | – | ﹤0.01% | 3106 |
|
2016
Q1 | $155K | Buy |
7,245
+11
| +0.2% | +$235 | ﹤0.01% | 2642 |
|
2015
Q4 | $229K | Buy |
7,234
+591
| +9% | +$18.7K | ﹤0.01% | 2480 |
|
2015
Q3 | $229K | Buy |
6,643
+220
| +3% | +$7.58K | ﹤0.01% | 2493 |
|
2015
Q2 | $202K | Buy |
6,423
+967
| +18% | +$30.4K | ﹤0.01% | 2705 |
|
2015
Q1 | $160K | Buy |
5,456
+73
| +1% | +$2.14K | ﹤0.01% | 2802 |
|
2014
Q4 | $100K | Buy |
5,383
+118
| +2% | +$2.19K | ﹤0.01% | 2906 |
|
2014
Q3 | $92K | Sell |
5,265
-5
| -0.1% | -$87 | ﹤0.01% | 3013 |
|
2014
Q2 | $105K | Buy |
+5,270
| New | +$105K | ﹤0.01% | 3012 |
|